June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Corneal crosslinking ameliorates degree of corneal edema in subsequent acute keratoconus
Author Affiliations & Notes
  • Claus Cursiefen
    Dept. of Ophthalmology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • Wei Zhang
    Dept. of Ophthalmology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • yanhong hou
    Dept. of Ophthalmology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • shuja deng
    Dept. of Ophthalmology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • Antonia Howaldt
    Dept. of Ophthalmology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • Felix Bock
    Dept. of Ophthalmology, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • Footnotes
    Commercial Relationships   Claus Cursiefen Roche, Code C (Consultant/Contractor), Medupdate, Code C (Consultant/Contractor), Ziemer, Code R (Recipient); Wei Zhang None; yanhong hou None; shuja deng None; Antonia Howaldt None; Felix Bock None
  • Footnotes
    Support  German Reserach Council DFG FOR 2240 (www.for2240.de)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2409 – A0212. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Claus Cursiefen, Wei Zhang, yanhong hou, shuja deng, Antonia Howaldt, Felix Bock; Corneal crosslinking ameliorates degree of corneal edema in subsequent acute keratoconus. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2409 – A0212.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corneal edema in acute keratoconus is caused by a sudden break of Descemet membrane. This study aims to assess whether pre-treatment with corneal crosslinking (CXL) can ameliorate corneal edema in a subsequent hydrops.

Methods : Normal or keratoconic human tissue (obtained during penetrating keratoplasty; n=6 each) was incubated with Corneal Culture Medium (CCM) I for hydration for 1 day and then dehydrated with CCM II for 24 hours. Then either CXL with 30-minutes topical application of 0.1% riboflavin followed by a 30-minutes UVA irradiation (3mW/cm2) or riboflavin only (in controls) followed. Afterwards, tissues were incubated with CCM I and central corneal thickness was measured using OCT (before treatment: hydration, dehydration; after treatment: overnight, 1 day, 2 days, 4 days). In the vivo experiment, C57BL/6 mice received CXL or only riboflavin (controls). Fourteen days later, a linear perforating incision was performed as murine model of acute keratoconus. Corneal thickness was measured by OCT after incision at 15 and 30 minutes, 1 and 4 hours, 1, 7 and 14 days (thickness from 5 naïve mice as the baseline).

Results : In the ex vivo experiments, crosslinked normal and keratoconic tissue had a significantly reduced swelling after rehydration: For normal corneas (normalized to “Dehydration”), the percentage of increase in thickness between Dehydration and 24 hours was 15.87% in the CXL group and 89.3% in controls (P=0.0019). For keratoconus corneas, results were 6.53% in CXL-treated and 38.2% in controls (P=0.0323). In the in vivo experiment, the average corneal thickness was significantly reduced in the treatment group at 15 minutes, 4 hours and 1 day post treatment compared to the controls (P<0.05).

Conclusions : CXL seems to ameliorate acute swelling of normal and keratoconic human corneas. Also, it can ameliorate the degree of early corneal edema in subsequent acute keratoconus in the murine model.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×